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Abstract: Snake venom metalloproteinases (SVMPs) and snake venom serine proteinases (SVSPs)
are among the most abundant enzymes in many snake venoms, particularly among viperids.
These proteinases are responsible for some of the clinical manifestations classically seen in viperid
envenomings, including hemorrhage, necrosis, and coagulopathies. The objective of this study was
to investigate the enzymatic activities of these proteins using a high-throughput peptide library
to screen for the proteinase targets of the venoms of five viperid (Echis carinatus, Bothrops asper,
Daboia russelii, Bitis arietans, Bitis gabonica) and one elapid (Naja nigricollis) species of high medical
importance. The proteinase activities of these venoms were each tested against 360 peptide substrates,
yielding 2160 activity profiles. A nonlinear regression model that accurately described the observed
enzymatic activities was fitted to the experimental data, allowing for the comparison of cleavage
rates across species. In this study, previously unknown protein targets of snake venom proteinases
were identified, potentially implicating novel human and animal proteins that may be involved in
the pathophysiology of viper envenomings. The functional relevance of these targets was further
evaluated and discussed. These new findings may contribute to our understanding of the clinical
manifestations and underlying biochemical mechanisms of snakebite envenoming by viperid species.
Keywords: snake venom proteinases; high-throughput; peptide substrates; proteinase activity;
screening; modeling; enzymatic profile
Key Contribution: The implementation and potential of a high-thoughput screening method for
substrates of snake venom proteinases.
1. Introduction
Snake venoms are highly complex mixtures of proteins and peptides, comprising enzymes,
non-enzymatic proteins and polypeptides from a wide range of families, and other bioactive
components [1,2]. Proteinases are prevalent enzymes in the venoms of snakes in the Viperidae
family [3–6], and are often the main drivers of toxicity for viperid venoms. These enzymes are known to
affect a large number of physiological pathways and response cascades, assisting in immobilization and
death. In addition, venom proteinases play a role in digesting prey, as well as deterring predators [7].
Proteinases have the ability to cleave other proteins by the hydrolysis of peptide bonds, whereby these
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other proteins may become activated or deactivated. In turn, this may modulate different physiological
processes involved in homeostasis [8].
Among the various families of venom proteinases, those present in snake venoms predominantly
belong to snake venom metalloproteinases (SVMPs) and snake venom serine proteinases (SVSPs).
SVMPs are known to contribute to the pathophysiology of envenomings by causing inflammation,
hemorrhage, blistering, skin damage, coagulopathy, and tissue necrosis in prey and patients [9].
In addition, they contribute to the hemodynamic alterations associated with viperid snakebite
envenomings as a consequence of hypovolemia [10]. SVMPs may affect the hemostatic system
through various mechanisms, such as activating prothrombin or coagulation factor X, exhibiting
fibrinolytic and fibrinogenolytic activities, or inhibiting platelet aggregation [11]. SVSPs are capable of
interacting similarly with the processes and components of the coagulation cascade. These enzymes
degrade fibrinogen or promote coagulation and platelet aggregation by activating or inactivating
several coagulation factors [12]. In addition, SVSPs cleave plasma proteins to generate kinins and
other bioactive agents [13].
In some cases, snake venom proteinases are highly similar to the human proteinases involved
in normal physiological processes. Many SVSPs are considered thrombin-like enzymes due to their
structural similarities with thrombin, their targets, and their involvement in coagulation processes [14].
SVSPs are classified in a mixed endopeptidases group (the “PA” clan), S01 family, subfamily A of
proteolytic enzymes by the MEROPS classification system (https://www.ebi.ac.uk/merops/) [15].
SVMPs, on the other hand, exhibit high similarity with ADAM (a disintegrin and metalloproteinase)
group of human metalloproteinases [16], and are also classified in the same proteinase family, according
to the MEROPS database (clan MA, family M12, subfamily B). Due to these similarities, elucidating the
mechanisms of action and the targets of snake venom proteinases may prove important in other fields
of biomedical research.
SVMPs are divided into three major classes, depending on the structural domains present in the
given SVMP. The first and the simplest class of SVMPs (P-I) contain only a single metalloproteinase
domain in the mature protein. The second class (P-II) contains SVMPs with a disintegrin domain
and a metalloproteinase domain. The third and most complex class (P-III) consists of SVMPs
with a metalloproteinase domain, a spacer, a disintegrin-like domain, and a cysteine-rich domain.
Additionally, several subclasses within each class exist [17]. SVSPs have been categorized into different
functional subtypes, including thrombin-like enzymes, kallikrein-like or blood pressure-reducing
enzymes, plasminogen activators, and platelet aggregation inhibitors or inducers [18]. For both
proteinase types, substrate specificity is regulated by conserved residues in the enzyme binding
pockets, with different variations between subfamilies.
Snake venom proteinase activity has traditionally been investigated by the purification of a
selected enzyme, followed by biochemical characterization. In these studies, the enzymatic activity
of proteinases is examined in assays using general protein substrates, such as azocasein [19],
by zymography [20], or with known targets of these enzymes, such as fibrinogenolytic, procoagulant,
and platelet aggregation assays [12,14,21,22]. Recent studies have focused on the substrate specificity
of proteinases of interest by the proteomic identification of cleavage sites. Using established
purification and mass spectrometry methods, substrate specificity models for said proteinases can be
constructed [23,24].
Proteinase activity can be measured in homogeneous assays, relying on a physical change
following substrate catalysis. In detection assays, the change is often assessed by measuring a
fluorescent or chromogenic signal from a synthetic peptide substrate upon cleavage by the proteinase.
Proteinases tolerate some degree of substrate modification, making the addition of reporter groups
in synthetic peptides feasible. Fluorescence resonance energy transfer (FRET) assays can be used
in cases where the integrity of the P’ residues (residues following the cleavage site) of the substrate
must be preserved [25]. To enable these assays to have a positive indication of proteinase activity,
a variation of the assay where an acceptor–donor pair that allows maximum overlap between emission
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and absorption are used. The acceptor acts as a quencher when in close proximity, e.g., before cleavage,
with the measured emission being close to zero. Upon cleavage, the moiety is separated, and the
fluorophore emission can be measured using fluorescence readers [26].
In this study, we demonstrate the use of the donor–acceptor detection method for the investigation
of proteinase activity of selected crude venoms in a high-throughput setup. An overview of this
method can be seen in Figure 1. With the use of a proteinase substrate set, consisting of substrates
described to be cleaved by proteinases in the literature, we were able to gain insights into the proteinase
activity of several medically relevant snake venoms. The total proteinase activity of these venoms
was analyzed and compared. The use of this high-throughput substrate screening method also shows
promise in unveiling novel target substrates of snake venom proteinases that could be involved in the
pathophysiology of envenomings.
Figure 1. Overview of the experimental method used in this study. The snake venoms obtained were
incubated with a peptide substrate set, yielding activity profiles for each peptide, across all snake
venoms. The profiles were analyzed further to determine if the cleavage of a given target peptide was
observed, and the rate of said cleavage (Section 2.3).
2. Results
2.1. Proteinase Activity Measurements Confirm Known Targets and Reveal New Substrate Sequences
Venoms from the snake species Bitis gabonica, Bitis arietans, Daboia russelii, Echis carinatus, Bothrops
asper (family Viperidae), and Naja nigricollis (family Elapidae) were subjected to proteinase activity
screening experiments. In total, 2160 activity profiles for these snake venoms against 360 different
peptide targets were acquired. These profiles were examined for the magnitude of the proteinase
activity, and the target specificity of the snake venoms. Based on the modeling parameter estimation of
activity, and the number of cleaved substrates of these snake venoms in the substrate set as a whole,
the highest activity was observed for the venoms of E. carinatus, B. arietans, and B. asper.
The substrate screening set contained several peptide sequences originating from proteins known
to be snake venom proteinase substrates. These included prothrombin, fibrinogen, other coagulation
factors, integrins, and collagen-derived sequences. Examples of venom proteinase activity against
these peptides are given in Figure 2.
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Figure 2. Measurements of selected substrates for all snake venoms (intensity measured in RFU:
relative fluorescence units, see Section 4.3). The common name of the protein of origin is shown
as a title of each plot. The Uniprot IDs and amino acid sequences of these substrates were:
(a) FA8_HUMAN–PQLRMKNN, (b) FIBB_CHICK–IDARAHRP, (c) THRB_HUMAN–IDGRIVEG,
(d) KNG1_HUMAN–SPFRSSRI, (e) ITA6_HUMAN–RPIPITAS, and (f) CO1A2_HUMAN–FYRADQPR.
In a number of cases, different activity levels were detected for venoms against multiple peptides
derived from the same proteins. This implies that the residue specificity plays a larger role in substrate
recognition than the target selectivity. Figure 3 shows the different activities of the studied snake
venoms against multiple candidate substrates originating from human and bovine prothrombin.
Figure 3. Measurements of substrates from human and bovine prothrombin (intensity measured in
RFU). The plots are annotated with the Uniprot ID of the protein and the amino acid sequence of
the substrate.
Apart from known snake venom proteinase substrates, high activity was also observed against
other hitherto unknown substrates of venom proteinases. These peptides were derived from proteins
that, to our knowledge, have no known cleavage sites for snake venom proteinases. These targets
might be involved in snake venom pathophysiology, contributing to the toxic effects exerted by venom
toxins or, alternatively, might reflect the overall digestive action of snake venom proteinases. Examples
of these targets are shown in Figure 4.
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Figure 4. Measurements of selected substrates for all snake venoms (intensity
measured in RFU). The common name of the protein of origin is shown as a title of
each plot. The Uniprot IDs and amino acid sequences of these substrates were: (a)
TNFL6_HUMAN–SLEKQIGH, (b) CTNB1_HUMAN–ADIDGQYA, (c) X3CL1_HUMAN–AATRRQAV,
(d) CCL7_HUMAN–QPVGINTS, (e) IL1B_HUMAN–GPYELKAL, and (f) C1R_HUMAN–QRQRIIGG.
The majority of snake venoms showed high activity for peptide substrates derived from proteins
known to be inflammation mediators, such as tumor necrosis factor ligands, interleukins, kininogen,
and complement system components. The exact influence of proteinase activity on these substrates
remains unknown, but it is hypothesized that this activity may impact inflammatory processes around
the bite site during envenoming.
2.2. Inhibition of Metalloproteinase Activity Provides Insights on Targets of Both Proteinase Families
In order to assess the proteinase activity of each of the two prominent proteinase families,
SVMPs and SVSPs, additional experiments with the addition of the metalloproteinase inhibitor
o-phenanthroline were carried out. The metal ion chelator o-phenanthroline has proven to be a potent
inhibitor of all proteinases of the metalloproteinase family, due to its mechanism of action depriving the
catalytic ions from these proteinases. The venoms that showed high activity in the original experiments
(namely E.carinatus, B. arietans and B. asper) were incubated with o-phenanthroline prior to the peptide
screenings (see Section 4.2).
In general, the addition of the inhibitor abolished the activity against a large number of peptide
targets, indicating the predominance of SVMPs in the overall proteolysis. However, the venoms
showed significant differences in the decrease of activity and the number of substrates that they
cleaved (see Section 2.4). For example, activity from the original experiments was retained for a high
number of peptides after the addition of metalloproteinase (MP) inhibitor to the venom of E. carinatus,
while in the case of B. asper and B. arietans, the activity was considerably reduced. Examples of
substrates against which the activity was abolished, or retained are shown in Figures 5–7.
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Figure 5. Measurements of selected substrates for the venom of E. carinatus, in the whole
venom experiment (original) and in the metalloproteinase inhibition experiment (intensity
measured in RFU). The common name of the protein of origin is shown as a title of each plot.
The Uniprot IDs and amino acid sequences of these substrates were: (a) FIBB_CHICK–IDARAHRP,
(b) TRAF3_HUMAN–EEADSMKS, (c) THRB_HUMAN–IDGRIVEG, (d) CO3_HUMAN–GLARSNLD,
(e) FURIN_HUMAN–FWHRGVTK, and (f) FA8_HUMAN–IEPRSFSQ.
Many substrates that retained activity in the presence of the inhibitor were sequences derived
from coagulation factors and inflammation mediators. Cleavage activity against peptides containing
arginine residues was highly overrepresented.
Figure 6. Measurements of selected substrates for the venom of B. asper, in the whole venom
experiment (original) and in the metalloproteinase inhibition experiment (intensity measured in
RFU). The common name of the protein of origin is shown as a title of each plot. The Uniprot
IDs and amino acid sequences of these substrates were: (a) CO1A2_HUMAN–GPQGLLGA,
(b) CCL7_HUMAN–QPVGINTS, (c) CO3_ONCMY–LLSRSEED, (d) KNG1_HUMAN–SPFRSSRI,
(e) C1R_HUMAN–QRQRIIGG, and (f) FIBA_HUMAN–GGVRGPRV.
Apart from the clear cases where the proteinase activity was either abolished or retained, certain
substrates showed higher rates of turnover in the experiments with the inhibitor compared to the
original experiments without the inhibitor, as can be seen in Figure 6d,f and Figure 7e. High cleavage
activity against these substrates was observed in the different snake venom profiles tested with the
MP inhibitor.
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Figure 7. Measurements of selected substrates for the venom of B. arietans, in the whole venom
experiment (original) and in the metalloproteinase inhibition experiment (intensity measured
in RFU). The common name of the protein of origin is shown as a title of each plot.
The Uniprot IDs and amino acid sequences of these substrates were: (a) IL1B_HUMAN–GPYELKAL,
(b) ITAV_HUMAN – DPLEFKSH, (c) TNFL6_HUMAN–SLEKQIGH, (d) KNG1_HUMAN–SPFRSSRI,
(e) FA8_HUMAN–RSKRALKQ, and (f) TNF13_HUMAN–RKRRAVLT.
2.3. Models of Proteinase Activity
The proteinase activity profiles were used to generate a model of the enzymatic activity of the
proteinases in the snake venoms of the study. Nonlinear modeling was performed to estimate the
parameters of cleavage activity by whole snake venom, using a model that has previously been utilized
to describe proteinase kinetics [25,27,28] (for details, see Section 4.3). The 2160 rate constants calculated
for all of the substrates across the six studied venoms will be referred to as rates in the remaining
sections for simplification. Examples of the model’s fit with experimental data can be seen in Figure 8.
Figure 8. Selected substrates with fits of the model to experimental data. The model fits are represented
as dashed lines, and the experimental fluorescence readings at different time points as scatter plots.
The y-axis shows arbitrary fluorescence units (AFU), and the x-axis shows time (minutes). The common
name of the protein of origin is shown as a title of each plot. The Uniprot IDs and amino acid sequences
of these substrates were: (a) TNFL6_HUMAN–SLEKQIGH and (b) KNG1_BOVIN–SPFRSVQV.
The parameter estimation was performed directly on the signal intensity measurements (AFU),
with the rates being in units AFU/hour. Values above 0.1 indicate at least some substrate cleavage,
and values above 1 indicate high and fast substrate turnover. Values below 0.01 indicate very low,
or undetectable cleavage activity, as shown in Figure 1. The estimated rates for all of the substrates
were used for further analysis to examine and compare the proteinase activity across the snake venoms
of our study. Looking at the distribution of these rates, as shown in Figure 9, the venoms of E. carinatus,
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B. arietans, and B. asper exhibited the highest rates in the full substrate set, followed by B. gabonica
venom, and then by D. russelii venom. The lowest rates were observed for N. nigricollis venom,
as expected, as this elapid snake venom is known to have low proteinase content [29].
Figure 9. Histograms showing the distribution of the rates >1 × 10−3 across the six snake venoms
subjected to investigation in this study, along with the inhibition experiments for the three snake
venoms with the highest activity. Rates for substrates against which no activity was observed (rate <1
× 10−3) are not shown. The x-axis shows the rates in the log base 10 scale, while the y-axis shows
occurrence (the number of substrates).
Experiments for E. carinatus, B. asper, B. arietans, and D. russelii venoms were replicated to assess
the reproducibility of the cleavage activities measured in each substrate plate. In general, the replicated
profiles were highly similar, with a low number of inconsistencies between them, e.g., false positives
or false negatives. A comparison of the rate estimates showed a high Pearson correlation between all
replicates (E. carinatus 0.93, B. asper 0.79, B. arietans 0.81, and D. russelii 0.71, also seen in Figure S1).
For these four snake venoms, the rates estimated for each of the experiments for any given peptide
were averaged (geometric mean) when used in further analyses (see Section 4.3 for details).
2.4. Substrate Cleavage Determination of Studied Venoms
In order to distinguish between cleaved and non-cleaved target peptides from the activities
observed, cutoff values for both fluorescence signal intensity and the estimated rates were applied
(see Section 4.4). Using these thresholds, a proposed number of cleaved substrates were determined
for each venom tested. As shown in Table 1, B. asper venom cleaved the most substrates, followed
closely by the venom of E. carinatus, and then by the venom of B. arietans, while the venoms of
B. gabonica, N. nigricolllis, and D. russelii show much lower numbers of cleaved substrates. As shown
in the previous subsection, although N. nigricollis has a few more cleaved substrates than D. russelii
that passed the strict cutoffs imposed, the venom of D. russelii showed activity rates above the rate
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threshold for more substrates. Both of these venoms showed very low proteinase activity relative to
the four other snake species.
Table 1. Quantification of substrate cleavage across the studied snake venoms, in absolute number
of substrates and as a percentage of the full substrate set. The cleaved substrates in the experiments
where the venoms are treated with the inhibitor phenanthroline (PT) are shown on the right.
Venom Substrates Venom % of Substrates Substrates Venom + PT % of Substrates
B. asper 98 27.2 21 5.8
E. carinatus 95 26.3 70 19.4
B. arietans 76 21.1 32 8.8
B. gabonica 15 4.1
D. russelii 8 2.2
N. nigricollis 13 3.6
It is noted that there was a small number of peptides (about half of them common between
snake venoms) that did not pass the cutoffs in the original experiments, but did so in the inhibitor
experiments. Consequently, the substrates cleaved in the inhibitor experiments are not entirely a subset
of the substrates cleaved in the original experiments. A full list of peptide targets determined as cleaved
for the snake venoms tested with and without the addition of the inhibitor, that could be potential
metalloproteinase or serine proteinase substrates, can be found in File S1. The venom of E. carinatus
retained 70% of its activity in the inhibition experiment compared to the original experiment, and was
the venom with the highest activity in the inhibition experiments. On the other hand, the venoms
of B. arietans and B. asper had approximately 40% and 20% of their original activity in the inhibition
experiments. The substrates that passed the cutoffs imposed in the inhibition experiments, which were
presumed to be SVSP substrates, were to a large extent common among the snake venoms, as can be
seen in Figure 10.
Figure 10. Venn diagram of the substrates that passed the cutoffs set, in the inhibitor-treated venom
experiments. Since the activity of snake venom metalloproteinases (SVMPs) is inhibited in these
experiments, these substrates are assumed to be targets of snake venom serine proteinases (SVSPs).
E. carinatus shows the highest number of cleaved substrates, while many cleaved substrates are common
between venoms. B. arietans and B. asper exhibit a low number of unique substrates.
2.5. Investigation of Relevant Targets for Human Snakebite Envenoming
As previously mentioned, the substrate set contained a number of target peptides derived from
proteins that are or could be relevant for understanding envenoming pathophysiology. These substrates
were grouped according to the biological process that they mediate, and the proteinase activity rates of
the studied snake venoms were compared for these targets. Figure 11 shows heatmaps of substrates
derived from relevant proteins in snakebite envenomings and their respective estimated rates for
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each snake venom tested. This method was employed to provide an overview of the snake venom
proteinase activity in three distinct groups of substrates, namely coagulation-derived, inflammation
mediator-derived, and collagen and integrin-derived substrate sequences. In addition, the presence
of cleavage sites that are characteristic of metalloproteinases and serine proteinases in these peptide
substrates are annotated in the figure.
Figure 11. Heatmaps of coagulation factors (A), inflammation-associated proteins (B), and collagen
and integrin-derived peptides (C) present in the substrate set used in the experiments. The cleavage
activity for these substrates is indicated by the intensity of the respective box color. The scale of
cleavage activity exhibited by the investigated venoms against these substrates is indicated by the
estimated rate of substrate turnover, which is shown here as the base 10 logarithm of the rate. The
substrates are identified by their Uniprot IDs. Substrates originating from the same protein are grouped
together, as indicated by the vertical bars (substrate sequences not shown). The most left column
(protease type) on the respective heatmap displays known cleavage sites in the substrate peptides for
the two proteinase families extracted from the MEROPS database. It should be noted that MEROPS
cleavage sites may be from any known metalloproteinase or serine proteinase, and not necessarily from
snake venom proteinases.
The highest proteinase activity for proteins of the coagulation cascade was observed in the venoms
of E. carinatus, B. arietans, and B. asper, although all of the viperid venoms showed activities against
a wide range of peptides derived from coagulation factors. The highest activities were exhibited
against substrates originating from coagulation factors V, VII, and VIII. A human prothrombin-derived
substrate (IDGRIVEG) was highly cleaved when incubated with the venoms of D. russelii and
E. carinatus, and by B. asper to a lesser extent. High activity was also observed against a human
fibrinogen alpha chain peptide (GGVRGPRV) for the venoms of B. gabonica and B. asper. All of the
venoms showed relatively low proteinase activity against a peptide (FSARGHRP) derived from human
fibrinogen beta chain.
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High proteinase activity was exhibited against substrates with inflammation mediator-derived
sequences in a more uniform manner for all viperid venoms. The highest activities against all of these
substrates were observed for the venoms of E. carinatus, B. arietans, and B. asper. D. russelii venom
also had a considerable activity against peptides derived from inflammation-associated substrates,
compared to the general low activity of this venom in the full substrate set. The most prominent
target peptides with high cleavage rates were complement system components and tumor necrosis
factor ligand substrates. High cleavage rates were also observed for substrates in other cytokines,
such as human fractaline (AATRRQAV), C-C motif chemokine 7 (QPVGINTS), kininogen-1 (SPFRSSRI),
and heat shock protein HSP 90-beta (DEEDDSGK).
High proteinase activity was also observed against peptides derived from collagen and integrin
proteins (Figure 11). Significant signal intensity for all of the viperid venoms, except D. russelii,
was observed against a peptide derived from human integrin alpha V (DPLEFKSH). High activity
was also detected against peptides derived from human integrin alpha 6 (RPIPITAS), human integrin
alpha X (RVLGLKAH), and integrin alpha 9 (VKRRVQDV). Viperid venoms showed high activity
against collagen type I and collagen type II derived substrates. Collagen type IV-derived peptides
were less labile to cleavage. Exceptions were observed, namely for the venom of E. carinatus on the
peptide substrate derived from human collagen alpha 1 (IV) chain (GPPGIPGQ) and collagen alpha 3
(IV) chain (DGLPGLKG). Considerable activity was observed against the peptide substrate derived
from Gallus gallus (chicken) collagen alpha 1 (X) chain (GPAGLSVL) and collagen alpha 1 (II) chain
(RYMRADEA). In general, the venom of E. carinatus showed high activity against collagen and integrin
substrates, followed by the venoms of B. arietans and B. asper.
The proteinase activity observed in the full substrate set in the inhibition experiments was greatly
reduced compared to the original experiments, indicating that most of the proteinase activity in snake
venoms is due to the action of SVMPs (Figure S2). However, E. carinatus venom retained high activity,
especially against the substrates examined in this section. Most of the substrates that were cleaved
in the inhibition experiments were peptides derived from coagulation factors and inflammation
mediators. E. carinatus retained its activity in almost all of the peptides derived from coagulation
factors V and VIII, while the peptides derived from coagulation factor VIII were susceptible to cleavage
by all three venoms treated with MP inhibitor (E. carinatus, B. asper, B. arietans). Fibrinogen alpha chain
(GGVRGPRV) was still cleaved by the venoms of E. carinatus and B. asper, while B. arietans showed no
activity on this peptide with or without MP inhibitor. The high activity against a substrate derived
from human prothrombin (IDGRIVEG) by the venom of E. carinatus was completely suppressed in the
inhibition experiments. Proteinase activity was also lost against a peptide originating from bovine
prothrombin (IEGRTSED), where all three venoms showed activity in the absence of an inhibitor.
Activity was retained against the fractaline substrate (AATRRQAV) for the venoms of E. carinatus
and B. arietans, but not for the venom of B. asper. The activity against HSP90 beta (DEEDDSGK),
IL1 beta (GPYELKAL), and CCL7 (QPVGINTS) substrates by all three venoms was abolished in the
inhibitor experiments. On the other hand, activity against peptides derived from kininogen 1 human
(SPFRSSRI) and bovine (SPFRSVQV) was still observed for all three venoms in the presence of an MP
inhibitor. A human TNFA (LAQAVRSS) substrate was cleaved only by the venom of E. carinatus in the
inhibition experiments, while a human TNF13 substrate (RKRRAVLT) was still highly cleaved by the
venoms of E. carinatus and B. arietans. The activity against human complement C1r subcomponent
(QRQRIIGG) was retained in all three venoms. The venom of E. carinatus kept its activity in all
complement-derived substrates, while the venoms of B. arietans and B. asper lost their activity in all
complement peptides, apart from the one mentioned. That was also the case in collagen and integrin
substrates, where B. arietans and B. asper venoms lost their activity, and E. carinatus venom retained its
activity in all but three examples (CO4A1, CO4A3, COAA1).
As previously mentioned, a significant number of substrates showed rates of substrate turnover
that were higher in the inhibition experiments than in the original experiments. The substrates
exhibiting higher rates were highly consistent across the three venoms tested with the addition of
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inhibitor. All of the substrates shown in Figure 11 against which activity was observed in the inhibition
experiments contained arginine residues in their sequences, apart from one (IL18, LESDYFGK, for the
venom of E. carinatus).
2.6. Comparison of Activities Reveals Phylogeny-Related Differences
In order to investigate the similarities and differences between the proteinase activities of the
studied snake venoms, the Jaccard similarity coefficient was employed as a similarity measure.
The estimated rates from the modeling of proteinase activity were discretized (see Section 4.5) to
indicate whether cleavage activity was present or not.
As can be seen in Figure 12A, the highest similarities were observed for the venoms of E. carinatus
with B. arietans, and B. asper with B. arietans. The tree (Figure 12B) shows the phylogenetic relationship
of the studied snake species. The species of the Bitis genus are found to be closely related; the snake
species of D. russelii and E. carinatus were grouped together, while the elapid N. nigricollis was
an out-group, as anticipated. Relationships based on the Jaccard similarities observed between
proteinase activities were considerably different than the phylogenetic relationship between these
species (Figure 12).
Figure 12. (A) Jaccard similarity comparing the activities of each snake venom against the rest of the
studied venoms. (B) Phylogenetic tree showing relationship between the species of this study, adapted
from [30].
3. Discussion
This study investigated the overall proteolytic activity of the venoms from the medically
relevant snake species of two families from different regions of the world. The results of the
high-throughput peptide screening analysis not only provide a general overview of the magnitude
of proteinase activity for each snake venom, but also provide insights into relevant targets for the
enzymes involved in the pathophysiology of snakebite envenomings. The high-throughput method
was effective in investigating multiple candidate substrates of proteinases, instead of a single or
limited number that can be tested by traditional spectrophotometric, SDS-PAGE, or zymography
techniques [19,20,31–33]. Typically, the thorough characterization of the proteinase substrate requires
a combination of electrophoretic techniques such as SDS-PAGE or 2D-DIGE, and mass spectrometry
methodologies (LC-MS/MS, MALDI-TOF) [34–38], although recently developed MS techniques can be
used without the need for an electrophoretic step [39–41]. However, these methods are quite laborious,
compared to the substrate profiling method used in this study. Although this screening method
does not provide the same amount of information in terms of cleavage site specificity, this technique
Toxins 2019, 11, 170 13 of 23
is an adequate first step for the identification of proteinase substrates. In the context of snakebite
envenoming, this study presents an easy, fast, and robust method to identify the targets of snake
venom proteinases that could play a role in envenomings. Moreover, this approach allows for the
identification of hitherto unknown substrates of snake venom enzymes, with possible implications for
understanding the mechanism of action of venoms.
Cleavage activity was observed against substrates originating from known targets of snake venom
proteinases, such as prothrombin, fibrinogen, other coagulation factors, integrins, and collagens.
The interaction of these proteins with snake venom components is well described in the literature [42–
46]. However, cleavage site locations and residues for these proteins have not previously been
thoroughly investigated. Thus, method employed in this study could allow a more in-depth
examination of substrates that are highly labile against snake proteinases in order to determine the
specificity determining residues upstream and downstream of the cleavage sites. The same approach
can be implemented for less described targets of snake venom proteinases. For example, the cleaved
peptides with sequences derived from complement system components could be the primary step in
the further investigation of the activity of proteinases on these proteins, and how these activities might
affect envenoming pathology [47,48].
The proteolytic activity was analyzed using the experimental measurements and the modeling
of said activity. When the full substrate set was considered, the highest activity was exhibited by
E. carinatus, followed closely by B. arietans and B. asper. Interestingly, the activity of B. arietans venom
showed more similarities with the above venoms compared to B. gabonica venom, which belong to
the same genus. D. russelli venom showed lower overall proteolytic activity, but was more selective
in terms of substrate cleavage, meaning that the activity observed reached higher values in these
substrates. N. nigricollis venom exhibited the lowest proteinase activity, as expected from an elapid
venom with different mechanisms of action and a low abundance of proteinases [29]. In general,
the observed proteolytic activity indicated a strong relationship between the number of cleaved
peptides and the overall proteinase abundance and the SVMP abundance in the snake venoms studied
(Tables 1 and 2).
Table 2. Relative abundance of snake venom proteinases in the studied venoms, according to
proteomic studies, along with a quantification of hemorrhagic and coagulant activities of the venoms
(minimum venom dose required to induce hemorrhage and coagulation, respectively), as described in
the indicated references. SVSPs: snake venom serine proteinases.
Venom Proteinase% SVMPs% SVSPs% Min. HemorrhagicDose (µg)
Min. Coagulant
Dose (µg)
E. carinatus 61.2 [49] 56.6 4.6 0.30 [50] 3.30 [50]
B. asper 59.2 [51] 41.0 18.2 1.50 [52] 0.32 [52]
B. arietans 57.9 [53] 38.5 19.5 0.15 [54] Non-coagulant
B. gabonica 54.7 [55] 30.8 23.9 0.38 [54] Non-coagulant
D. russelii 25.0 [56] 21.8 3.2 4.30 [50] 4.00 [50]
N. nigricollis 2.4 [29] 2.4 - Non-hemorrhagic [57] Non-coagulant
In this relation, it is to be noted that wide intraspecies variations in snake venom compositions
exist between specimens obtained from different geographical regions [58–60]. For the present analyses,
proteinase abundances for the studied venoms were based on values reported in published venomics
studies for representative species from geographical regions similar or identical to the region reported
by the venom supplier [61]. More specifically, as can be seen in Table 2, E. carinatus venom contains
a high abundance (about 60%) of snake venom metalloproteinases, with B. asper and B. arietans
venoms having similar abundances (about 40%). The results of the inhibition experiments suggest that
E. carinatus has the highest serine proteinase activity.
In general terms, proteinases in venoms play two main adaptive roles, i.e., toxicity leading to
prey immobilization, killing, and digestion [9]. Proteinase-induced toxicity depends on the cleavage of
selected targets of known physiological relevance, such as clotting factors, extracellular matrix proteins
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of the basement membrane of blood vessels, and precursors of inflammatory mediators, among others.
D. russelii showed a reduced overall proteinase activity as compared to the other viperid venoms
analyzed, in agreement with previous observations using azocasein as a substrate [50]. However,
proteinases play a key role in the pathophysiology induced by this venom, as exemplified by an SVMP
that activates factor X of the coagulation cascade, which is a key aspect in the hemostatic alterations
characteristic of D. russelii-induced envenomings [62].
There is a number of described snake venom proteinases that could be responsible for the activities
observed against certain relevant substrates. The MEROPS database provides an annotation of the
substrates of proteinases. In some cases, the substrates of this study matched the sequence and protein
of origin of substrates of these described proteinases, which makes them great candidates for explaining
the activity observed in the experiments of this study. A P-III SVMP from E. carinatus venom, ecarin,
is a known prothrombin activator. E. carinatus venom demonstrated high activity against a peptide
(IDGRIVEG) derived from human prothrombin, which is among the known substrates of ecarin [63].
Another described metalloproteinase from E. carinatus venom, carinactivase, has a known target site
in prothrombin, four residues upstream of the ecarin target site [64]. The activity against this human
prothrombin substrate was completely abolished when the venom of E. carinatus was treated with
o-phenanthroline, indicating that SVMPs were largely responsible for the substrate cleavage activity
against this substrate. High proteinase activity was observed against the same prothrombin-derived
substrate in our experiments for the venom of D. russelii. Another metalloproteinase from E. carinatus
venom, lebetase, targets known substrate sequences in kininogen [65]. Partial sequences of these
kininogen-derived substrates were among the substrates of this study (SPFRSSRI and SPFRSVQV),
where E. carinatus venom showed the highest activity. For other peptides originating from prothrombin,
the highest activities were observed for E. carinatus and B. asper venoms. B. asper venom also contains
a known prothrombin-activating metalloproteinase, basparin, although no cleavage sites for this
proteinase have been described [66]. B. asper venom contains another metalloproteinase with known
fibrigenolytic activity called BaP1 [67]. The presence of this proteinase could explain the high activity
that B. asper venom exhibited against a peptide derived from fibrinogen alpha chain (GGVRGPRV)
in the experiments of this study. The same substrate was quite labile toward B. gabonica venom,
which contains a serine proteinase called gabonase. This specific sequence of the fibrinogen alpha
chain is a known substrate cleavage site of gabonase [68]. It is worth noting that two more known
substrate sequences targeted by gabonase were among the substrates of this study, originating from
fibrinogen beta chain (FSARGHRP) and factor XIII (VVPRGVNL). However, B. gabonica venom had
little to no activity against these substrates. Lastly, a known factor X activating the metalloproteinase
from the venom of D. russelii, russelysin, has annotated X factor sequences as its substrate cleavage
sites [69]. Partial regions of this sequence (P1 and P’ residues) were found in substrates originating
from factor VIII (PQGRIVGG), factor XI (IKPRIVGG), and kallikrein (TSTRIVGG). D. russelii venom
showed considerable activity for these substrates.
Our observations on the degradation of peptides from various types of proteins playing distinct
roles in physiology may provide clues to the action of these venom proteinases. Of particular interest
is the hydrolysis of sequences of proteins involved in the coagulation cascade or inflammation, those
that are part of the extracellular matrix, and integrins. Regarding proteins of the clotting cascade,
heatmap analysis showed that the venoms of E. carinatus, B. asper, B. arietans, and B. gabonica showed
the highest activity, followed by D. russelii. From a functional standpoint, the proteolysis of a clotting
factor may result in two different outcomes: (a) the factor may be activated, as in the case of SVMPs
that activate factor X or prothrombin, and SVSPs that convert fibrinogen into fibrin [70], or (b) the
factor might be degraded to an inactive form. For an example of the latter, two of the peptides in this
study that were derived from coagulation factors V and VIII are known to contain the cleavage sites of
activated protein C, which is an anticoagulant proteinase among others (these two substrates were
highly cleaved by E. carinatus and B. arietans, and to a lesser extent by B. asper). These two actions
have highly different pathophysiological consequences. This duality is evident when analyzing the
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heat maps of coagulation cascade proteins vis-à-vis the in vitro coagulant activity of venoms (Table 2).
The venoms of the two Bitis species are able to degrade several peptides from clotting factors without
being coagulant in vitro, whereas the venom of D. russelii cleaves a fewer number of substrates, and yet
has in vitro clotting activity. Likewise, the hydrolysis of proteins playing roles in the inflammatory
response may be associated with the cleavage of a precursor and the release of an active component,
such as the case in the hydrolysis of pro-tumor necrosis alpha (TNF) described for the venom of Echis
ocellatus [71] or the activation of complement factors [72]. In contrast, the hydrolysis of inflammatory
mediators may result in inactivation. Hence, the widespread hydrolysis observed for sequences of a
number of inflammatory mediators by venom proteinases may play positive and negative modulatory
roles in the inflammatory response.
Analysis of the cleavage sites of extracellular matrix proteins and integrins also revealed higher
collagenolytic activity in the venoms displaying an overall higher proteinase activity, i.e., B. asper,
E. carinatus, and the two species of Bitis. Collagen hydrolysis has been associated with the degradation
of the extracellular matrix, which characterizes the severe local tissue pathology that is characteristic of
viperid snakebite envenoming induced by the action of SVMPs [73]. There is a relationship between the
number of collagen-derived peptides cleaved and the hemorrhagic activity of venoms (Table 2). Among
viperid venoms, D. russelii shows the lowest number of cleaved peptides and the lowest hemorrhagic
activity, whereas the venom of N. nigricollis is not hemorrhagic and cleaves few collagen-derived
peptides. The hydrolysis of peptides with sequences derived from integrins may also have implications
for the actions of these venoms, as these proteins play key roles in cell–cell and cell–extracellular matrix
interactions. In particular, the high activity observed in four viperid venoms against integrin alpha V,
and in the light of the viperid venoms inducing skin blistering, may have implications due to the known
role of this integrin in the skin [74]. The observation of the hydrolysis of peptides with sequences
derived from intracellular proteins may bear functional implications on two grounds. (a) Upon cell
death by the action of venom cytotoxins, intracellular components are exposed, and therefore prone
to hydrolysis by venom proteinases, thus contributing to the overall digestion of tissues. (b) Some
products of proteolysis may acquire functional roles of various sorts, becoming mediators of cellular
activation or constituting damage-associated molecular patterns (DAMPs), which participate in the
overall tissue response to venoms [75]. Among the substrates tested in this work, HSP 90 beta
(DEEDDSGK) has been described as a DAMP [75].
The proteinase activity against the substrates studied exhibited different steady-state levels
(level of fluorescence signal where the activity seems to be saturated), as measured by the fluorescence
intensity measurements. The different steady-state levels might be explained by the aggregate effect
of a different number of proteinases that are responsible for the cleavage possess of the specific
substrate sequences in the same venom, differences in the amount of labeled peptide loaded in each
well, or inadequate duration of the assay for the given target peptide to reach its steady-state level.
In some cases, a drop-off in fluorescence readings was observed at later time points. This drop-off
from the maximum fluorescence measured in earlier stages could be caused by re-quenching of the
fluorophores by free quenchers in the solution, or by photobleaching, rendering the fluorophores
unable to fluoresce. The observation of higher rates for a number of substrates in the experiments where
the metalloproteinase inhibitor phenanthroline was added is intriguing, and cannot easily be explained.
However, speculations on the cause of this phenomenon can be mentioned. It is possible that the
SVMPs were limiting the availability of a given substrate for cleavage by serine proteinases, by binding
to the substrate, or preventing it from binding to serine proteinases in the original experiments.
Inhibiting SVMPs with the chelator phenanthroline, and subsequently destabilizing them by the loss
of the metal ion, would eliminate the scenario, resulting in higher rates for the substrates of serine
proteinases. Another possible explanation could be that the serine proteinase activity was limited in
the original experiments, but not in the inhibition experiments. Moreover, the occurrence of higher
rates for certain substrates in the inhibition experiments would be attained if SVMPs from the snake
venoms were cleaving, and thereby inactivating serine proteinases in the original experiments. Finally,
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it might be possible that other snake venom components were affecting the cleavage activity of serine
proteinases on substrates, and that the inhibition of the serine proteinase activity was removed in the
inhibition experiments by the interaction of these assumed components with the inhibitor.
The cleavage detection method of this study proved to be an adequate indicator of proteinase
cleavage activity and a useful tool for comparing the snake venom proteinase activities against a
standardized set of targets. Expanding this datasets by the screening of more snake venoms would
provide a wider framework for the investigation of the scale of proteinase activity in these venoms,
as well as allow the examination of the differences and similarities in these activities. This method
of cleavage detection also shows promise in the identification and discovery of targets of specific
proteinases. By incubating purified proteinases with selected peptide targets of interest, several
potentially relevant targets of these proteinases could be screened, and the proteinase activity against
these substrates could be assessed. Moreover, this method could present significant value outside of
the boundaries of snakebite envenoming research. The determination of substrate cleavage for proteins
of clinical importance in other fields could demonstrate the possibility of utilizing specific snake venom
proteinases as ‘tools’ for scientific research and drug development in these disciplines [76,77].
4. Materials and Methods
4.1. Snake Venoms
Snake venoms of interest were purchased in lyophilized form (Latoxan S.A.S., Valence, France).
The venoms of B. gabonica (L1104A, Burundi), B. arietans (L1159A, Tanzania), N. nigricollis
(L1327B, Tanzania), D. russelii (L1132A, Pakistan), E. carinatus sochureki (L1111, Pakistan), and B. asper
(L1209B, Costa Rica) were obtained as pooled samples from several specimens.
4.2. Proteinase Activity and Inhibition Experiments
The enzymatic activity of each venom was tested using the Protease Substrate Set (JPT Peptide
Technologies GmbH, Berlin, Germany). The JPT Peptide Technologies Protease Substrate Set is a
384-well plate with 360 different 8-mer peptides derived from natural protein cleavage sites described
in the scientific literature. The remaining 24 wells are reserved for controls. The 360 peptides are
flanked by a quencher molecule (DABCYL) and a fluorophore Glu(EDANS)-amide at the N-terminus
and the C-terminus, respectively. These two moieties are separated upon peptide cleavage, allowing
the EDANS molecule to fluoresce. Brij L23, 30% w/v (B4184, Sigma-Aldrich, St. Louis, MO, USA)
was diluted to 0.03% w/v and used for the suspension of the freeze-dried peptides in the substrate
set (10 µL per well). The venoms were resuspended to a starting concentration of 300 µg/mL in
0.03% w/v Brij solution. Then, 5 µL of venom suspension was added to each plate well for a final
concentration of 100 µg/mL. The concentration for the peptide substrates in the wells was 5 µM at
a final volume of 15 µL. In each experiment, nine wells were loaded with control solutions: 3 wells
with Brij solution (0.03% w/v), 3 wells with venom (300 µg/mL), and 3 wells with venom (100 µg/mL)
and Brij solution (0.03% w/v) at a volume of 15 µL. Fluorescence was measured using a Cytation
5 Imaging Reader (BioTek Instruments, Winooski, VT, USA) at different time points, with excitation at
350 nm and emission at 490 nm, according to the plate manufacturer’s instructions. For the venoms of
B. gabonica, B. arietans, and N. nigricollis measurements were collected at seven different time points:
0 (background), 30, 60, 90, 120, 180, and 240 min. For the venoms of D. russelii, B. asper, and E. carinatus,
additional measurements were taken at 15 and 45 min for greater resolution in the early stages of the
enzymatic activity.
The metalloproteinase inhibition experiments were conducted following the same protocol as
described above, with the exception that the metalloproteinase inhibitor was added in the venoms
after their suspension. The metalloproteinase inhibitor 1,10-phenanthroline (P9375, Sigma-Aldrich)
was dissolved in methanol and diluted to a 200 mM stock solution. The inhibitor was added to
the suspended venoms and the solution was incubated at 37 ◦C for 30 min, with the final inhibitor
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concentration of 10 mM in the substrate plate wells. The pH of the venom solution was not affected by
the addition of the inhibitor. The control solution triplicates used were the same as above, with the
addition of phenanthroline in the suspended venoms. Measurements were taken for the background
signal intensity and eight different time points, as mentioned above. The raw data obtained from all of
the experiments are available in File S2.
4.3. Data Analysis and Modeling
The analysis of the experimental data was conducted with Python 3.6 [78], using the Python
packages Numpy 1.13.3 [79], Pandas 0.20.3 [80]. Matplotlib 2.1.0 [81] and Seaborn 0.9.0 [82] were used
for data visualization and figure generation. Kinetic parameter estimation was performed using the
function optimize.curve_fit (Scipy 0.19.1 [83]), and statistical significance tests were carried out with
the Scipy and StatsModels 0.8.0 [84] packages.
Relative fluorescence graphs were constructed by the subtraction of the base-2 logarithm values
of the background measurements from the base-2 logarithm values of the later time points, for each
well signal intensity. The following equation was used to describe product accumulation:
P(t) = Pmax(1 − e−αt) (1)
which has previously been used to describe proteinase kinetics in experiments utilizing fluorescence
assays [25], and phage substrate methods [27], along with equations to convert fluorescence in FRET
assays to substrate concentration [28]. This equation was adjusted to allow for different levels of
background fluorescence (Fmin) and different maximum fluorescence levels (Fmax). Thus, the equation
used to model proteinase activity was the following:
F(t) = (Fmax − Fmin) × (1 − e−λt) + Fmin (2)
where the Fmax, Fmin, and the rate constant λ were estimated for all of the proteinase activity profiles.
The Fmin and Fmax parameters were initialized using the minimum and maximum fluorescence values
observed. An initial value of 10−5 was used for the rates, indicating an activity level well below
detection. Initialization using different λ values did not affect the final estimations. In cases where
the background measurement (Fmin) was slightly higher than in later time points (mostly evident
in N. nigricollis venom substrate activity profile), overestimation of the rate constants was observed.
For that reason, the background estimates were subtracted from all of the fluorescence measurements,
and negative values at later measurements (in the rare cases that the signal intensity was slightly lower
than the background measurements) were set to zero. Consequently, the Fmin of the model was also
zeroed. In the inhibition experiments, the fluorescence signal emission caused by phenanthroline
was subtracted from the measurements, using the average of the triplicate controls that were present.
The estimation of the parameters and model fitting was done after the measurements were adjusted
for the fluorescence drop-off of the later measurements, in the limited instances that this phenomenon
occurred. Lower and upper boundaries of 0 and 15 AFU/hour were used for λ estimation. Wells that
showed maximum fluorescence intensity below the arbitrary cutoff of 5000 AFU were disregarded
as having negligible or no activity, and the rates of those wells were reinitialized and not used for
subsequent analysis. In the cases where duplicates of the experiments existed, the rates estimated
for each of the experiments for any given peptide were averaged using the geometric mean of the
two values. The estimated rates for all of the peptide targets across all of the venoms can be found in
File S3.
4.4. Substrate Cleavage
For a given substrate to be deemed as cleaved by a certain venom, two cutoffs had to be satisfied:
one for the estimated rates and one the fluorescence signal intensity, respectively. A cleavage rate
above 1 (100) and a fluorescence measurement value of above 50% of the 95th percentile value of the
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fluorescence signal observed on each substrate plate (to account for the variances of fluorescence
signal in the different plates) was needed. These cutoffs had to be satisfied in the first two hours
of measurements.
4.5. Jaccard Similarity Coefficient and Phylogeny
After analyzing the estimated model parameters, it was apparent that for each comparison,
the rates could be grouped in four different categories. For each substrate, these were: cleavage
activity by both snake venoms, negligible or no activity for either, activity for one and not for the
other, or vice versa. The Jaccard coefficient was employed to assess the similarities between venom
activities, as it has been used successfully to describe various biological interactions and processes that
could be classified as binary [85,86]. The model rate parameters were discretized into two ranges of
values (10−5 to 10−1 and 10−1 to 15), making it possible to classify them into undetectable or very low
activity (assigned zero) and considerable activity (assigned one) cleavage using a cutoff value of 10−1.
The Jaccard coefficient was calculated using the equation:
J = R11/(R11 + R10 + R01) (3)
where R11 is the number of the discretized rates assigned one for both snake venoms, and R10 and
R01 are the number of discretized rates that were assigned one for one of the snake venom activities
and zero for the other, respectively.
The phylogenetic tree of the snake species in this study was created by pruning of the original
phylogenetic tree constructed in [30], retaining only the species of interest from the newick file of
the referenced study. Pruning was conducted in Python 2.7 using the objects and the prune function
of the ete2 [87] phylogenetic analysis package. The distances between species were omitted for
better visualization.
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6651/11/3/170/s1,
Figure S1: Correlation plots of replicate experiments for the snake venoms of B. arietans, B. asper, E. carinatus,
and D. russelii, Figure S2: Heatmaps of coagulation factors (A), inflammation-associated proteins (B), and collagen
and integrins (C) comparing the proteinase activity in the selected peptide targets in the original experiments and
the experiments with the addition of inhibitor, File S1: Excel file containing assumed metalloproteinase substrates
and assumed serine proteinase substrates for the snake venoms of B. arietans, B. asper, and E. carinatus, File S2:
Excel file containing all of the fluorescence intensity measurement data from all of the experiments conducted,
File S3: Excel file containing all of the estimated rate constants for all of the snake venom experiments conducted
in this study.
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